BUY Glenmark Pharmaceuticals — Motilal Oswal
byMotilal OswalHorizon: NA (inferred 1 year)11 Jul 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
1 other SEBI-registered advisor has an active long-term SELL call on this stock
Advisor consensus · same horizon·3 Feb · 3mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Glenmark Pharmaceuticals
- BUY — Prakash Gaba21 Oct 2026 · Same day · target ₹2,300 · SL hit
- BUY — Somil Mehta, Sharekhan19 Oct 2026 · ~2 weeks · target ₹2,400 · Active
- BUY — Osho Krishan, Angel One13 Oct 2026 · ~2 weeks · target ₹2,400 · Active
- BUY — Manas Jaiswal9 Oct 2026 · ~2 weeks · target ₹2,375 · SL hit
- BUY — Prakash Gaba9 Oct 2026 · ~2 weeks · target ₹2,350 · SL hit
More from Motilal Oswal
- BUY Emcure Pharmaceuticals21 Oct 2026 · ~1 year · target ₹2,330 · Active
- BUY Aditya Birla Sun Life AMC21 Oct 2026 · ~1 year · target ₹1,160 · Active
- BUY Mahindra & Mahindra Financial Services21 Oct 2026 · ~1 year · target ₹375 · Active
- BUY Hindalco Industries21 Oct 2026 · ~1 year · target ₹1,170 · Active
- BUY Eternal21 Oct 2026 · ~1 year · target ₹420 · Active

